Olema
San Francisco, US · Founded 2007 · 183 employees on LinkedIn · 5 known investors
Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance. It focuses on improving treatment outcomes for patients living with breast cancer.
Investors · 5
In the news
Frequently asked questions
- What does Olema do?
- Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance. It focuses on improving treatment outcomes for patients living with breast cancer.
- Who are Olema's investors?
- Olema's investors include Avoro Capital Advisors, Bain Capital Life Sciences, Lightspeed Venture Partners, RA Capital, Vivo Capital.
- Where is Olema headquartered?
- Olema is headquartered in San Francisco, US.

